Advertisement
Review Article| Volume 49, ISSUE 1, P181-194, March 2022

Biomarkers of Necrotizing Enterocolitis: The Search Continues

Published:January 21, 2022DOI:https://doi.org/10.1016/j.clp.2021.11.011
      NEC (Necrotizing Enterocolitis), GI (Gastointestinal), WBC (White blood cell count), I-FABP (Intestinal fatty acid-binding protein), TFF3 (Intestinal trefoil factors), CRP (C-reactive Protein), PCT (Procalcitonin), IMA (Ischemia-modified Albumin), IAIP (Inter-Alpha Inhibitor Protein), SAA (Serum Amyloid A Protein), PGE-MUM (Prostaglandin E Major Urinary Metabolite), C5a (Complement component 5a), LOS (Late onset sepsis)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Perinatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Neu J.
        • Walker W.A.
        Necrotizing enterocolitis.
        N Engl J Med. 2011; 364: 255-264
        • Holman R.C.
        • Stoll B.J.
        • Curns A.T.
        • et al.
        Necrotising enterocolitis hospitalisations among neonates in the United States.
        Paediatr Perinat Epidemiol. 2006; 20: 498-506
        • Bazacliu C.
        • Neu J.
        Necrotizing enterocolitis: long term complications.
        Curr Pediatr Rev. 2019; 15: 115-124
        • Federici S.
        • De Biagi L.
        Long term outcome of infants with NEC.
        Curr Pediatr Rev. 2019; 15: 111-114
        • Stoll B.J.
        • Hansen N.I.
        • Bell E.F.
        • et al.
        Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network.
        Pediatrics. 2010; 126: 443-456
        • Shah T.A.
        • Meinzen-Derr J.
        • Gratton T.
        • et al.
        Hospital and neurodevelopmental outcomes of extremely low-birth-weight infants with necrotizing enterocolitis and spontaneous intestinal perforation.
        J Perinatol. 2012; 32: 552-558
        • Eaton S.
        • Rees C.M.
        • Hall N.J.
        Current research in necrotizing enterocolitis.
        Early Hum Dev. 2016; 97: 33-39
        • D’Angelo G.
        • Impellizzeri P.
        • Marseglia L.
        • et al.
        Current status of laboratory and imaging diagnosis of neonatal necrotizing enterocolitis.
        Ital J Pediatr. 2018; 44: 84
        • Strimbu K.
        • Tavel J.A.
        What are biomarkers?.
        Curr Opin HIV AIDS. 2010; 5: 463-466
        • Gordon P.V.
        • Swanson J.R.
        • Attridge J.T.
        • et al.
        Emerging trends in acquired neonatal intestinal disease: is it time to abandon Bell's criteria?.
        J Perinatol. 2007; 27: 661-671
      1. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.
        Clin Pharmacol Ther. 2001; 69: 89-95
        • Caplan M.S.
        • Underwood M.A.
        • Modi N.
        • et al.
        Necrotizing enterocolitis: using regulatory science and drug development to improve outcomes.
        J Pediatr. 2019; 212: 208-215.e201
        • Giannone P.J.
        • Luce W.A.
        • Nankervis C.A.
        • et al.
        Necrotizing enterocolitis in neonates with congenital heart disease.
        Life Sci. 2008; 82: 341-347
        • Torrazza R.M.
        • Li N.
        • Neu J.
        Decoding the enigma of necrotizing enterocolitis in premature infants.
        Pathophysiology. 2014; 21: 21-27
        • Patel R.M.
        • Ferguson J.
        • McElroy S.J.
        • et al.
        Defining necrotizing enterocolitis: current difficulties and future opportunities.
        Pediatr Res. 2020; 88: 10-15
        • Gordon P.V.
        • Swanson J.R.
        Necrotizing enterocolitis is one disease with many origins and potential means of prevention.
        Pathophysiology. 2014; 21: 13-19
        • Lueschow S.R.
        • Boly T.J.
        • Jasper E.
        • et al.
        A critical evaluation of current definitions of necrotizing enterocolitis.
        Pediatr Res. 2021; https://doi.org/10.1038/s41390-021-01570-y
        • Ng P.C.
        • Ma T.P.Y.
        • Lam H.S.
        The use of laboratory biomarkers for surveillance, diagnosis and prediction of clinical outcomes in neonatal sepsis and necrotising enterocolitis.
        Arch Dis Child Fetal Neonatal Ed. 2015; 100: F448-F452
        • Ng P.C.
        Biomarkers of necrotising enterocolitis.
        Semin Fetal Neonatal Med. 2014; 19: 33-38
        • Ng P.C.
        An update on biomarkers of necrotizing enterocolitis.
        Semin Fetal neonatal Med. 2018; 23: 380-386
        • Gordon P.V.
        • Swanson J.R.
        • Clark R.
        • et al.
        The complete blood cell count in a refined cohort of preterm NEC: the importance of gestational age and day of diagnosis when using the CBC to estimate mortality.
        J Perinatology. 2016; 36: 121-125
        • Garg P.M.
        • O’Connor A.
        • Ansari M.A.Y.
        • et al.
        Hematological predictors of mortality in neonates with fulminant necrotizing enterocolitis.
        J Perinatology. 2021; 41: 1110-1121
        • Remon J.
        • Kampanatkosol R.
        • Kaul R.R.
        • et al.
        Acute drop in blood monocyte count differentiates NEC from other causes of feeding intolerance.
        J Perinatology. 2014; 34: 549-554
        • Ragazzi S.
        • Pierro A.
        • Peters M.
        • et al.
        Early full blood count and severity of disease in neonates with necrotizing enterocolitis.
        Pediatr Surg Int. 2003; 19: 376-379
        • Pourcyrous M.
        • Korones S.B.
        • Yang W.
        • et al.
        C-reactive protein in the diagnosis, management, and prognosis of neonatal necrotizing enterocolitis.
        Pediatrics. 2005; 116: 1064-1069
        • Cetinkaya M.
        • Ozkan H.
        • Köksal N.
        • et al.
        Comparison of the efficacy of serum amyloid A, C-reactive protein, and procalcitonin in the diagnosis and follow-up of necrotizing enterocolitis in premature infants.
        J Pediatr Surg. 2011; 46: 1482-1489
        • Turner D.
        • Hammerman C.
        • Rudensky B.
        • et al.
        Low levels of procalcitonin during episodes of necrotizing enterocolitis.
        Dig Dis Sci. 2007; 52: 2972-2976
        • Maheshwari A.
        • Schelonka R.L.
        • Dimmitt R.A.
        • et al.
        Cytokines associated with necrotizing enterocolitis in extremely-low-birth-weight infants.
        Pediatr Res. 2014; 76: 100-108
        • Benkoe T.
        • Baumann S.
        • Weninger M.
        • et al.
        Comprehensive evaluation of 11 cytokines in premature infants with surgical necrotizing enterocolitis.
        PLoS One. 2013; 8: e58720
        • Terrin G.
        • Stronati L.
        • Cucchiara S.
        • et al.
        Serum markers of necrotizing enterocolitis: a systematic review.
        J Pediatr Gastroenterol Nutr. 2017; 65: e120-e132
        • Cheng S.
        • Yu J.
        • Zhou M.
        • et al.
        Serologic intestinal-fatty acid binding protein in necrotizing enterocolitis diagnosis: a meta-analysis.
        Biomed Res Int. 2015; 2015: 156704
        • Luo J.
        • Li H.P.
        • Xu F.
        • et al.
        Early diagnosis of necrotizing enterocolitis by plasma RELMβ and thrombocytopenia in preterm infants: a pilot study.
        Pediatr Neonatol. 2019; 60: 447-452
        • Maheshwari A.
        Immunologic and hematological abnormalities in necrotizing enterocolitis.
        Clin Perinatol. 2015; 42: 567-585
        • Mohd Amin A.T.
        • Zaki R.A.
        • Friedmacher F.
        • et al.
        C-reactive protein/albumin ratio is a prognostic indicator for predicting surgical intervention and mortality in neonates with necrotizing enterocolitis.
        Pediatr Surg Int. 2021; 37: 881-886
        • Edelson M.B.
        • Bagwell C.E.
        • Rozycki H.J.
        Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis.
        Pediatrics. 1999; 103: 766-771
        • Tayman C.
        • Tonbul A.
        • Kahveci H.
        • et al.
        C5a, a complement activation product, is a useful marker in predicting the severity of necrotizing enterocolitis.
        Tohoku J Exp Med. 2011; 224: 143-150
        • Chaaban H.
        • Shin M.
        • Sirya E.
        • et al.
        Inter-alpha inhibitor protein level in neonates predicts necrotizing enterocolitis.
        J Pediatr. 2010; 157: 757-761
        • Shah B.A.
        • Migliori A.
        • Kurihara I.
        • et al.
        Blood level of inter-alpha inhibitor proteins distinguishes necrotizing enterocolitis from spontaneous intestinal perforation.
        J Pediatr. 2017; 180: 135-140.e1
        • Yang G.
        • Wang Y.
        • Jiang X.
        Diagnostic value of intestinal fatty-acid-binding protein in necrotizing enterocolitis: a systematic review and meta-analysis.
        Indian J Pediatr. 2016; 83: 1410-1419
        • Heida F.H.
        • Hulscher J.B.
        • Schurink M.
        • et al.
        Intestinal fatty acid-binding protein levels in Necrotizing Enterocolitis correlate with extent of necrotic bowel: results from a multicenter study.
        J Pediatr Surg. 2015; 50: 1115-1118
        • Yakut I.
        • Tayman C.
        • Oztekin O.
        • et al.
        Ischemia-modified albumin may be a novel marker for the diagnosis and follow-up of necrotizing enterocolitis.
        J Clin Lab Anal. 2014; 28: 170-177
        • Cetinkaya M.
        • Ozkan H.
        • Köksal N.
        • et al.
        The efficacy of serial serum amyloid A measurements for diagnosis and follow-up of necrotizing enterocolitis in premature infants.
        Pediatr Surg Int. 2010; 26: 835-841
        • Sylvester K.G.
        • Moss R.L.
        Urine biomarkers for necrotizing enterocolitis.
        Pediatr Surg Int. 2015; 31: 421-429
        • Harpole M.
        • Davis J.
        • Espina V.
        Current state of the art for enhancing urine biomarker discovery.
        Expert Rev Proteomics. 2016; 13: 609-626
        • Bakhoum C.Y.
        • Basalely A.
        • Koppel R.I.
        • et al.
        Acute kidney injury in preterm infants with necrotizing enterocolitis.
        J Matern Fetal Neonatal Med. 2019; 32: 3185-3190
        • Schurink M.
        • Kooi E.M.
        • Hulzebos C.V.
        • et al.
        Intestinal fatty acid-binding protein as a diagnostic marker for complicated and uncomplicated necrotizing enterocolitis: a prospective cohort study.
        PLoS One. 2015; 10: e0121336
        • Coufal S.
        • Kokesova A.
        • Tlaskalova-Hogenova H.
        • et al.
        Urinary intestinal fatty acid-binding protein can distinguish necrotizing enterocolitis from sepsis in early stage of the disease.
        J Immunol Res. 2016; 2016: 5727312
        • Evennett N.J.
        • Hall N.J.
        • Pierro A.
        • et al.
        Urinary intestinal fatty acid–binding protein concentration predicts extent of disease in necrotizing enterocolitis.
        J Pediatr Surg. 2010; 45: 735-740
        • Reisinger K.W.
        • Derikx J.P.M.
        • Thuijls G.
        • et al.
        Noninvasive measurement of intestinal epithelial damage at time of refeeding can predict clinical outcome after necrotizing enterocolitis.
        Pediatr Res. 2013; 73: 209-213
        • Okada K.
        • Sekino M.
        • Funaoka H.
        • et al.
        Intestinal fatty acid-binding protein levels in patients with chronic renal failure.
        J Surg Res. 2018; 230: 94-100
        • Coufal S.
        • Kokesova A.
        • Tlaskalova-Hogenova H.
        • et al.
        Urinary I-FABP, L-FABP, TFF-3, and SAA can diagnose and predict the disease course in necrotizing enterocolitis at the early stage of disease.
        J Immunol Res. 2020; 2020: 3074313
        • Reisinger K.W.
        • Kramer B.W.
        • Van der Zee D.C.
        • et al.
        Non-Invasive Serum Amyloid A (SAA) measurement and plasma platelets for accurate prediction of surgical intervention in severe necrotizing enterocolitis (NEC).
        PLoS One. 2014; 9: e90834
        • Niemarkt H.J.
        • de Meij T.G.
        • van de Velde M.E.
        • et al.
        Necrotizing enterocolitis: a clinical review on diagnostic biomarkers and the role of the intestinal microbiota.
        Inflamm Bowel Dis. 2015; 21: 436-444
        • Blackwood B.P.
        • Wood D.R.
        • Yuan C.Y.
        • et al.
        Urinary claudin-2 measurements as a predictor of necrotizing enterocolitis: a pilot study.
        J Neonatal Surg. 2015; 4: 43
        • Thuijls G.
        • Derikx J.P.M.
        • van Wijck K.
        • et al.
        Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis.
        Ann Surg. 2010; 251: 1174-1180
        • Konishi K.I.
        • Yoshida M.
        • Nakao A.
        • et al.
        Prostaglandin E-major urinary metabolite as a noninvasive surrogate marker for infantile necrotizing enterocolitis.
        J Pediatr Surg. 2019; 54: 1584-1589
        • Arai Y.
        • Matsuura T.
        • Matsuura M.
        • et al.
        Prostaglandin E-major urinary metabolite as a biomarker for inflammation in ulcerative colitis: prostaglandins revisited.
        Digestion. 2016; 93: 32-39
        • Gajda A.M.
        • Storch J.
        Enterocyte fatty acid-binding proteins (FABPs): different functions of liver and intestinal FABPs in the intestine.
        Prostaglandins Leukot Essent Fatty Acids. 2015; 93: 9-16
        • Guilmeau S.
        • Niot I.
        • Laigneau J.P.
        • et al.
        Decreased expression of Intestinal I- and L-FABP levels in rare human genetic lipid malabsorption syndromes.
        Histochem Cell Biol. 2007; 128: 115-123
        • van de Poll M.C.
        • Derikx J.P.
        • Buurman W.A.
        • et al.
        Liver manipulation causes hepatocyte injury and precedes systemic inflammation in patients undergoing liver resection.
        World J Surg. 2007; 31: 2033-2038
        • Shores D.R.
        • Fundora J.
        • Go M.
        • et al.
        Normative values for circulating intestinal fatty acid binding protein and calprotectin across gestational ages.
        BMC Pediatr. 2020; 20: 250
        • Derikx J.P.M.
        • Evennett N.J.
        • Degraeuwe P.L.J.
        • et al.
        Urine based detection of intestinal mucosal cell damage in neonates with suspected necrotising enterocolitis.
        Gut. 2007; 56: 1473-1475
        • Gollin G.
        • Stadie D.
        • Mayhew J.
        • et al.
        Early detection of impending necrotizing enterocolitis with urinary intestinal fatty acid-binding protein.
        Neonatology. 2014; 106: 195-200
        • Goldstein G.P.
        • Sylvester K.G.
        Biomarker discovery and utility in necrotizing enterocolitis.
        Clin Perinatol. 2019; 46: 1-17
        • Aamann L.
        • Vestergaard E.M.
        • Grønbæk H.
        Trefoil factors in inflammatory bowel disease.
        World J Gastroenterol. 2014; 20: 3223-3230
        • Griffiths V.
        • Al Assaf N.
        • Khan R.
        Review of claudin proteins as potential biomarkers for necrotizing enterocolitis.
        Irish J Med Sci. 2021; 190: 1465-1472
        • Ishida N.
        • Miyazu T.
        • Takano R.
        • et al.
        Prostaglandin E-major urinary metabolite versus fecal immunochemical occult blood test as a biomarker for patient with ulcerative colitis.
        BMC Gastroenterol. 2020; 20: 114
        • Lehmann F.S.
        • Burri E.
        • Beglinger C.
        The role and utility of faecal markers in inflammatory bowel disease.
        Ther Adv Gastroenterol. 2015; 8: 23-36
        • Aydemir O.
        • Aydemir C.
        • Sarikabadayi Y.U.
        • et al.
        Fecal calprotectin levels are increased in infants with necrotizing enterocolitis.
        J Matern Fetal Neonatal Me. 2012; 25: 2237-2241
        • Reisinger K.W.
        • Van der Zee D.C.
        • Brouwers H.A.
        • et al.
        Noninvasive measurement of fecal calprotectin and serum amyloid A combined with intestinal fatty acid-binding protein in necrotizing enterocolitis.
        J Pediatr Surg. 2012; 47: 1640-1645
        • MacQueen B.C.
        • Christensen R.D.
        • Yost C.C.
        • et al.
        Elevated fecal calprotectin levels during necrotizing enterocolitis are associated with activated neutrophils extruding neutrophil extracellular traps.
        J Perinatol. 2016; 36: 862-869
        • Qu Y.
        • Xu W.
        • Han J.
        • et al.
        Diagnostic value of fecal calprotectin in necrotizing enterocolitis: a meta-analysis.
        Early Hum Dev. 2020; 151: 105170
        • van Zoonen A.
        • Hulzebos C.V.
        • Muller Kobold A.C.
        • et al.
        Serial fecal calprotectin in the prediction of necrotizing enterocolitis in preterm neonates.
        J Pediatr Surg. 2019; 54: 455-459
        • Däbritz J.
        • Jenke A.
        • Wirth S.
        • et al.
        Fecal phagocyte-specific S100A12 for diagnosing necrotizing enterocolitis.
        J Pediatr. 2012; 161: 1059-1064
        • Jenke A.C.
        • Postberg J.
        • Mariel B.
        • et al.
        S100A12 and hBD2 correlate with the composition of the fecal microflora in ELBW infants and expansion of E. coli is associated with NEC.
        Biomed Res Int. 2013; 2013: 150372
        • Garner C.E.
        • Ewer A.K.
        • Elasouad K.
        • et al.
        Analysis of faecal volatile organic compounds in preterm infants who develop necrotising enterocolitis: a pilot study.
        J Pediatr Gastroenterol Nutr. 2009; 49: 559-565
        • Probert C.
        • Greenwood R.
        • Mayor A.
        • et al.
        Faecal volatile organic compounds in preterm babies at risk of necrotising enterocolitis: the DOVE study.
        Arch Dis Child Fetal Neonatal Ed. 2020; 105: 474-479
        • Ng P.C.
        • Chan K.Y.Y.
        • Lam H.S.
        • et al.
        A prospective cohort study of fecal miR-223 and miR-451a as noninvasive and specific biomarkers for diagnosis of necrotizing enterocolitis in preterm infants.
        Neonatology. 2020; 117: 555-561
        • de Meij T.G.
        • de Boer N.K.
        • Benninga M.A.
        • et al.
        Faecal gas analysis by electronic nose as novel, non-invasive method for assessment of active and quiescent paediatric inflammatory bowel disease: proof of principle study.
        J Crohns Colitis. 2014; https://doi.org/10.1016/j.crohns.2014.09.004
        • Course C.W.
        • Watkins J.
        • Muller C.
        • et al.
        Volatile organic compounds as disease predictors in newborn infants: a systematic review.
        J Breath Res. 2021; https://doi.org/10.1088/1752-7163/abe283
        • Pinu F.R.
        • Beale D.J.
        • Paten A.M.
        • et al.
        Systems biology and multi-omics integration: viewpoints from the metabolomics research community.
        Metabolites. 2019; 9: 76
        • Liu H.
        • Wang Y.B.
        Systematic large-scale meta-analysis identifies miRNA-429/200a/b and miRNA-141/200c clusters as biomarkers for necrotizing enterocolitis in newborn.
        Biosci Rep. 2019; 39 (BSR20191503)
        • Ng P.C.
        • Chan K.Y.Y.
        • Yuen T.P.
        • et al.
        Plasma miR-1290 is a novel and specific biomarker for early diagnosis of necrotizing enterocolitis-biomarker discovery with prospective cohort evaluation.
        J Pediatr. 2019; 205: 83-90.e10
        • Wu Y.Z.
        • Chan K.Y.Y.
        • Leung K.T.
        • et al.
        Dysregulation of miR-431 and target gene FOXA1 in intestinal tissues of infants with necrotizing enterocolitis.
        FASEB J. 2019; 33: 5143-5152
        • Jiang P.
        • Smith B.
        • Qvist N.
        • et al.
        Intestinal proteome changes during infant necrotizing enterocolitis.
        Pediatr Res. 2013; 73: 268-276
        • Murgas Torrazza R.
        • Li N.
        • Young C.
        • et al.
        Pilot study using proteomics to identify predictive biomarkers of necrotizing enterocolitis from buccal swabs in very low birth weight infants.
        Neonatology. 2013; 104: 234-242
        • Sylvester K.G.
        • Ling X.B.
        • Liu G.Y.
        • et al.
        Urine protein biomarkers for the diagnosis and prognosis of necrotizing enterocolitis in infants.
        J Pediatr. 2014; 164: 607-612.e1-7
        • Stewart C.J.
        • Nelson A.
        • Treumann A.
        • et al.
        Metabolomic and proteomic analysis of serum from preterm infants with necrotising entercolitis and late-onset sepsis.
        Pediatr Res. 2016; 79: 425-431
        • Chatziioannou A.C.
        • Wolters J.C.
        • Sarafidis K.
        • et al.
        Targeted LC-MS/MS for the evaluation of proteomics biomarkers in the blood of neonates with necrotizing enterocolitis and late-onset sepsis.
        Anal Bioanal Chem. 2018; 410: 7163-7175
        • Morrow A.L.
        • Lagomarcino A.J.
        • Schibler K.R.
        • et al.
        Early microbial and metabolomic signatures predict later onset of necrotizing enterocolitis in preterm infants.
        Microbiome. 2013; 1: 13
        • Sylvester K.G.
        • Kastenberg Z.J.
        • Moss R.L.
        • et al.
        Acylcarnitine profiles reflect metabolic vulnerability for necrotizing enterocolitis in newborns born premature.
        J Pediatr. 2017; 181: 80-85.e81
        • Rusconi B.
        • Jiang X.
        • Sidhu R.
        • et al.
        Gut sphingolipid composition as a prelude to necrotizing enterocolitis.
        Sci Rep. 2018; 8: 10984
        • Thomaidou A.
        • Chatziioannou A.C.
        • Deda O.
        • et al.
        A pilot case-control study of urine metabolomics in preterm neonates with necrotizing enterocolitis.
        J Chromatogr B Analyt Technol Biomed Life Sci. 2019; 1117: 10-21
        • Chaaban Hala
        • Markel Troy
        • Canvasser Jenifer
        • et al.
        Biobanking for necrotizing enterocolitis: Needs and standards.
        J Pediatr Surg. 2020; 55: 1276-1279https://doi.org/10.1016/j.jpedsurg.2019.05.002